These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28472527)

  • 41. Pathologic Correlation of Cellular Imaging Using Apparent Diffusion Coefficient Quantification in Patients with Brain Metastases After Gamma Knife Radiosurgery.
    Borghei-Razavi H; Sharma M; Emch T; Krivosheya D; Lee B; Muhsen B; Prayson R; Obuchowski N; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Mohammadi AM; Angelov L
    World Neurosurg; 2020 Feb; 134():e903-e912. PubMed ID: 31733389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
    Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
    J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.
    Brennan C; Yang TJ; Hilden P; Zhang Z; Chan K; Yamada Y; Chan TA; Lymberis SC; Narayana A; Tabar V; Gutin PH; Ballangrud Å; Lis E; Beal K
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):130-6. PubMed ID: 24331659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinguishing Brain Metastasis Progression From Radiation Effects After Stereotactic Radiosurgery Using Longitudinal GRASP Dynamic Contrast-Enhanced MRI.
    Berger A; Lee MD; Lotan E; Block KT; Fatterpekar G; Kondziolka D
    Neurosurgery; 2023 Mar; 92(3):497-506. PubMed ID: 36700674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
    Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH; Olson JJ; Oyesiku NM; Wait SD; Curran WJ; Shu HK; Prabhu RS
    Neurosurgery; 2016 Aug; 79(2):279-85. PubMed ID: 26528673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
    Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
    Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.
    Moraes FY; Winter J; Atenafu EG; Dasgupta A; Raziee H; Coolens C; Millar BA; Laperriere N; Patel M; Bernstein M; Kongkham P; Zadeh G; Conrad T; Chung C; Berlin A; Shultz DB
    Neuro Oncol; 2019 Feb; 21(2):242-251. PubMed ID: 30265328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis.
    Remick JS; Kowalski E; Khairnar R; Sun K; Morse E; Cherng HR; Poirier Y; Lamichhane N; Becker SJ; Chen S; Patel AN; Kwok Y; Nichols E; Mohindra P; Woodworth GF; Regine WF; Mishra MV
    Radiat Oncol; 2020 May; 15(1):128. PubMed ID: 32466775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radionecrosis (RN) in patients with brain metastases treated with stereotactic radiosurgery (SRS) and immunotherapy.
    Andring L; Squires B; Seymour Z; Fahim D; Jacob J; Ye H; Marvin K; Grills I
    Int J Neurosci; 2023 Feb; 133(2):186-193. PubMed ID: 33685315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
    Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
    Bougie E; Masson-Côté L; Mathieu D
    World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and Management of Progressive Enhancement After Radiation Therapy for Brain Metastases: Results from a Neurosurgical Survey.
    Semonche A; Patel NV; Yang I; Danish SF
    World Neurosurg; 2020 Jul; 139():e526-e540. PubMed ID: 32311550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reirradiation With Stereotactic Radiosurgery After Local or Marginal Recurrence of Brain Metastases From Previous Radiosurgery.
    Kowalchuk RO; Niranjan A; Lee CC; Yang HC; Liscak R; Guseynova K; Tripathi M; Kumar N; Peker S; Samanci Y; Hess J; Chiang V; Iorio-Morin C; Mathieu D; Pikis S; Wei Z; Lunsford LD; Trifiletti DM; Sheehan JP
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):726-734. PubMed ID: 34644606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.
    Sayan M; Şahin B; Mustafayev TZ; Kefelioğlu EŞS; Vergalasova I; Gupta A; Balmuk A; Güngör G; Ohri N; Weiner J; Karaarslan E; Özyar E; Atalar B
    Neurocirugia (Astur : Engl Ed); 2021; 32(6):261-267. PubMed ID: 34743823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Timing of Adjuvant Fractionated Stereotactic Radiosurgery Affects Local Control of Resected Brain Metastases.
    Roth O'Brien DA; Poppas P; Kaye SM; Mahase SS; An A; Christos PJ; Liechty B; Pisapia D; Ramakrishna R; Wernicke AG; Knisely JPS; Pannullo S; Schwartz TH
    Pract Radiat Oncol; 2021; 11(3):e267-e275. PubMed ID: 33578001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
    Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
    Kotecha R; Miller JA; Venur VA; Mohammadi AM; Chao ST; Suh JH; Barnett GH; Murphy ES; Funchain P; Yu JS; Vogelbaum MA; Angelov L; Ahluwalia MS
    J Neurosurg; 2018 Jul; 129(1):50-59. PubMed ID: 28799876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery.
    Admojo L; Korte J; Anderson N; Phillips C; Caspersz L; Lasocki A
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):292-298. PubMed ID: 36650724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.